Track Medtech Start-ups

Learn More

The Impact of COVID-19 on the Global Medical Device Industry


Letter from CEO

June 5, 2020

Our focus from the outset of the COVID-19 outbreak has been to protect the well-being of our employees while supporting our thousands of clients within the medtech ecosystem. During these uncertain times, our clients are making critical strategic decisions with serious short and long term implications to their businesses. LSI is here to provide the trusted data and intelligence required to support these decisions.

As your trusted medtech intelligence partner, we are committed to providing you with the data and insights you need to navigate these unprecedented times. Below are a few of the key priorities we’ve initially focused on to support our clients’ immediate needs:

  • Weekly monitoring, analysis, reporting of the impact COVID-19 is having on medtech markets
  • Complete update & re-forecasts of all segments of the global medical devices & diagnostics markets
  • Re-forecasts of our global surgical procedure volume databases
  • New virtual events and expanded startup database to support ongoing discovery/partnering between innovators, investors and strategics
  • Firm re-commitment and restructuring of our LSI 2021 conference to accommodate a safe and productive environment for this key industry in-person event

We remain committed to our employees and the medtech ecosystem during these unprecedented times. For more information relating to LSI’s products and services, please contact us at 714 847 3540 or via email at


Scott Pantel



Impact Tracker Launched

Impact of COVID-19 on Global Medical Devices & Diagnostics Markets


These regularly updated reports are included stand-alone or as part of our subscription based COVID-19 Impact Tracker Platform. 

In the report, our team of seasoned analysts forecast the impact of the current COVID-19 and associated economic crisis on the global medical devices and diagnostics (MD&D) market.  The forecast period is 2020-2024 and coverage includes:

  • Surgical Caseloads by Major Type
  • 30+ Technology Markets by Major Type 
  • Markets by Major Geography
  • Clinical Markets by Major Type
  • Competitor Exposure & Opportunity Profiles
  • Market Share Analysis; and
  • Much more.

This report will be essential to your understanding of how and when the overall market will rebound—including the likely long-term impact of the crisis on its growth—as well as which technologies and geographic markets will be most impacted. 

Impact of COVID-19 on Surgical Procedure Volumes: Elective, Non-Emergent, & Emergent Procedures


These databases are included stand-alone or as part of our subscription based COVID-19 Impact Tracker Platform. 

Each country-level database includes a detailed procedure volume forecast factoring in the impact of the crisis down to the procedure level.  Current data for 2020 plus rebound schedules through 2025 are included. 

The data are presented in Excel market models adapted from LSI's Global Surgical Procedure Volumes Database.  Weekly updates and full access to our team of analysts are available as an add-on service to help our customers navigate through this unprecedented time.

Procedure volumes are organized by type (elective, non-emergent and emergent) and broken down by medical segment, procedure and country.

Forecast Period

  •  2020-2025

Procedure Categorization

  • Elective (postpone)
  • Non-emergent (consider postponing)
  • Emergent (do not postpone)

Geographic Segmentation

  • Global data drilled down to the country level (37).

Markets Covered 

  • Aesthetics
  • Cardiovascular
  • Ear Nose Throat (ENT)
  • General Surgery
  • Neurosurgery
  • Obstetrics & Gynecology (OB/GYN)
  • Ophthalmology
  • Orthopedic
  • Peripheral Vascular
  • Spine
  • Stereotactic Radiosurgery (SRS)
  • Urological

Procedures Covered


Learn More Now